Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy-Reference-Cited by-同舟云学术

Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy

Published:2017-01-30 Issue:2 Volume:35 Page:217-226
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Tambo Yuichi,Hosomi Yukio,Sakai Hiroshi,Nogami Naoyuki,Atagi Shinji,Sasaki Yasutsuna,Kato Terufumi,Takahashi Toshiaki,Seto Takashi,Maemondo Makoto,Nokihara Hiroshi,Koyama Ryo,Nakagawa Kazuhiko,Kawaguchi Tomoya,Okamura Yuta,Nakamura Osamu,Nishio Makoto,Tamura Tomohide

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-017-0435-2.pdf

Reference32 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108

2. Li T, Kung HJ, Mack PC, Gandara DR (2013) Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. J Clin Oncol 31:1039–1049

3. Stinchcombe TE, Socinski MA (2009) Current treatments for advanced stage non-small cell lung cancer. Proc Am Thorac Soc 6:233–241

4. Shepherd FA, Dancey J, Ramlau R, Mattson K, Gralla R, O’Rourke M, Levitan N, Gressot L, Vincent M, Burkes R, Coughlin S, Kim Y, Berille J (2000) Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol 18:2095–2103

5. Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J, Gatzemeier U, Tsao TC, Pless M, Muller T, Lim HL, Desch C, Szondy K, Gervais R, Shaharyar, Manegold C, Paul S, Paoletti P, Einhorn L, Bunn PA Jr (2004) Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 22:1589–1597

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Tumor Strategies by Harnessing the Phagocytosis of Macrophages;Cancers;2023-05-11

2. What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives;Coordination Chemistry Reviews;2021-12

3. Resistance to platinum-based cancer drugs: a special focus on epigenetic mechanisms;Pharmacogenomics;2021-08

4. The Role of Histone Protein Acetylation in Regulating Endothelial Function;Frontiers in Cell and Developmental Biology;2021-04-29

5. Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends;Journal of Biomedical Science;2021-04-12